There is currently no text in this page. You can search for this page title in other pages, or search the related logs, but you do not have permission to create this page.
Category:CS1 maint: Multiple names: authors list
Jump to navigation
Jump to search
Pages in category "CS1 maint: Multiple names: authors list"
The following 200 pages are in this category, out of 20,488 total.
(previous page) (next page)A
- Adrenal insufficiency classification
- Adrenal insufficiency CT scan
- Adrenal insufficiency MRI
- Adrenal insufficiency overview
- Adrenal insufficiency pathophysiology
- Adrenal insufficiency physical examination
- Adrenal insufficiency resident survival guide
- Adrenal insufficiency x ray
- Adrenal metastases
- Adrenal myelolipoma
- Adrenergic myocarditis
- Adrenergic receptor
- Adrenocortical carcinoma causes
- Adrenocortical carcinoma classification
- Adrenocortical carcinoma CT
- Adrenocortical carcinoma differential diagnosis
- Adrenocortical carcinoma epidemiology and demographics
- Adrenocortical carcinoma historical perspective
- Adrenocortical carcinoma history and symptoms
- Adrenocortical carcinoma laboratory findings
- Adrenocortical carcinoma medical therapy
- Adrenocortical carcinoma MRI
- Adrenocortical carcinoma natural history
- Adrenocortical carcinoma other diagnostic studies
- Adrenocortical carcinoma other imaging studies
- Adrenocortical carcinoma pathophysiology
- Adrenocortical carcinoma physical examination
- Adrenocortical carcinoma radiation therapy
- Adrenocortical carcinoma risk factors
- Adrenocortical carcinoma staging
- Adrenocortical carcinoma surgery
- Adrenoleukodystrophy causes
- Adrenoleukodystrophy CT
- Adrenoleukodystrophy epidemiology and demographics
- Adrenoleukodystrophy future or investigational therapies
- Adrenoleukodystrophy historical perspective
- Adrenoleukodystrophy laboratory findings
- Adrenoleukodystrophy medical therapy
- Adrenoleukodystrophy MRI
- Adrenoleukodystrophy other imaging findings
- Adrenoleukodystrophy physical examination
- Adrenoleukodystrophy screening
- Adrenoleukodystrophy secondary prevention
- Adrenomedullin receptor
- Adrenorphin
- Adult bronchiolitis differential diagnosis
- Adult stem cell
- Adult T-cell leukemia CT
- Adult T-cell leukemia epidemiology and demographics
- Adult T-cell leukemia natural history, complications and prognosis
- Adult T-cell leukemia pathophysiology
- Adult T-cell leukemia risk factors
- Adult treatment panel guidelines (ATP III) for hypercholestrolemia
- Adult vaccinations
- Advance Care Planning
- Advance health care directive
- Advanced Cell Technology
- Advanced glycation endproduct
- Advanced trauma life support
- Adverse drug reaction
- Aedes aegypti
- Aedes albopictus
- Aerobactin synthase
- Aerodynamics
- Aerogel
- Aerometeor radiation astronomy
- Aeropyrum
- Afamelanotide
- AFCAPS/TexCAPS Trial
- Afimoxifene
- AFM (gene)
- AFP-L3
- AFREGS Trial
- African trypanosomiasis differential diagnosis
- African trypanosomiasis laboratory findings
- African trypanosomiasis overview
- Afrotheria
- Aft1p gene transcriptions
- Ag+-exporting ATPase
- Agaricus campestris
- Agatoxin
- AGC box gene transcription laboratory
- AGC box gene transcriptions
- AGCE gene transcriptions
- Ageing
- AGMAT
- Agni casti fructus
- Agomelatine
- Agoraphobia
- Agranulocytosis
- Agronomy
- AHA, ASA guidelines for stroke
- AHA/ASA guideline recommendations for prevention of stroke in women atrial fibrillation
- AHA/ASA guideline recommendations for prevention of stroke in women cerebral venous thrombosis
- AHA/ASA guideline recommendations for prevention of stroke in women menopause and postmenopausal hormonal therapy
- AHA/ASA guideline recommendations for prevention of stroke in women migraine with aura
- AHA/ASA guideline recommendations for prevention of stroke in women obesity, metabolic syndrome, and lifestyle factors
- AHA/ASA guideline recommendations for prevention of stroke in women oral contraceptives
- AHA/ASA guideline recommendations for prevention of stroke in women overview
- AHA/ASA guideline recommendations for prevention of stroke in women pregnancy and complications
- AHA/ASA guideline recommendations for prevention of stroke in women prevention
- AHA/ASA guideline recommendations for secondary prevention of stroke
- AHA/ASA Guidelines for the Definition and Evaluation of Transient Ischemic Attack
- Ahrensia
- Aicardi-Goutieres syndrome
- AICDA
- AIDS defining clinical condition
- AIDS dementia complex
- AIDS landmark trials
- AIDS pandemic
- AIDS/references
- AIF1
- AIM-HIGH Trial
- AIP (gene)
- Air embolism causes
- Air embolism CT
- Air embolism differential diagnosis
- Air embolism echocardiography or ultrasound
- Air embolism electrocardiogram
- Air embolism epidemiology and demographics
- Air embolism history and symptoms
- Air embolism laboratory findings
- Air embolism medical therapy
- Air embolism MRI
- Air embolism overview
- Air embolism physical examination
- Air embolism primary prevention
- Air embolism risk factors
- Air embolism secondary prevention
- AIR synthetase (FGAM cyclase)
- Ajuga nipponensis makino
- Akathisia
- AKR1A1
- AKR1C4
- Akshun syndrome
- ALA dehydratase deficiency
- Alagille Syndrome Diagnosis
- Alagille syndrome laboratory findings
- Alagille syndrome laboratory tests
- Alagille syndrome MRI
- Alagille syndrome natural history
- Alagille syndrome overview
- Alagille syndrome pathophysiology
- Alagille syndrome physical examination
- Alagille syndrome surgery
- Alanine-glyoxylate transaminase
- Alanopine dehydrogenase
- Alanylphosphatidylglycerol synthase
- Alaproclate
- Alatrofloxacin
- Albendazole monooxygenase
- Albert Einstein
- Albidovulum
- Albinism causes
- Albinism epidemiology and demographics
- Albinism historical perspective
- Albinism laboratory findings
- Albinism medical therapy
- Albinism natural history, complications and prognosis
- Albinism other diagnostic studies
- Albinism other imaging findings
- Albinism pathophysiology
- Albinism physical examination
- Alcohol dehydrogenase (acceptor)
- Alcohol detoxification
- Alcohol O-cinnamoyltransferase
- Alcohol withdrawal causes
- Alcohol withdrawal classification
- Alcohol withdrawal cost-effectiveness of therapy
- Alcohol withdrawal CT
- Alcohol withdrawal diagnostic criteria
- Alcohol withdrawal differential diagnosis
- Alcohol withdrawal future or investigational therapies
- Alcohol withdrawal historical perspective
- Alcohol withdrawal laboratory findings
- Alcohol withdrawal medical therapy
- Alcohol withdrawal natural history, complications and prognosis
- Alcohol withdrawal other diagnostic studies
- Alcohol withdrawal other imaging findings
- Alcohol withdrawal overview
- Alcohol withdrawal pathophysiology
- Alcohol withdrawal physical examination
- Alcohol withdrawal secondary prevention
- Alcoholic cardiomyopathy echocardiography
- Alcoholic cardiomyopathy epidemiology and demographics
- Alcoholic cardiomyopathy laboratory findings
- Alcoholic cardiomyopathy medical therapy
- Alcoholic cardiomyopathy natural history, complications and prognosis
- Alcoholic cardiomyopathy overview
- Alcoholic cardiomyopathy pathophysiology
- Alcoholic hepatitis causes
- Alcoholic hepatitis CT
- Alcoholic hepatitis epidemiology and demographics
- Alcoholic hepatitis MRI
- Alcoholic hepatitis natural history, complications and prognosis
- Alcoholic hepatitis other diagnostic studies
- Alcoholic hepatitis pathophysiology
- Alcoholic hepatitis primary prevention
- Alcoholic hepatitis risk factors
- Alcoholic hepatitis screening
Media in category "CS1 maint: Multiple names: authors list"
The following 11 files are in this category, out of 11 total.
-
1a3p egf.png 1,440 × 1,080; 241 KB
-
AHR functional domains.svg 1,500 × 400; 22 KB
-
Aldose reductase 1us0.png 1,000 × 878; 499 KB
-
ARISE Trial - lactate values.png 467 × 272; 9 KB
-
Aromatase 3EQM.png 1,440 × 1,080; 732 KB
-
Catechol-O-methyl transferase 3bwm.png 1,200 × 890; 488 KB
-
Cochrane.2020.pmid.32584464.png 596 × 407; 19 KB
-
COVID-19 - Dx testing.png 475 × 333; 15 KB
-
HoxB1-Pbx1 heterodimer binding DNA 1b72.png 1,000 × 1,321; 601 KB
-
NCEP guidelines.png 960 × 720; 14 KB
-
Table LDL goal.png 960 × 720; 4 KB